henhaobio
Sign in

mBioMicrobiologyPeer-reviewed journal article

Osmotic conditions shape fitness gains and resistance mechanisms during E. coli and T4 phage co-evolution

Michael HunteriD, Eric Lyall, Kriti VermaiD, Carolina TropiniiD

PDFDOIPreprint

Abstract

Environmental conditions strongly influence interactions between bacteria and bacterio-phages (phages). Here, we examined how osmolality (solute concentration) shapes the in vitro co-evolution of T4 phage and its host Escherichia coli during serial passage. When evolved independently, we observed substantial fitness gains in both bacteria and phages, particularly in high osmotic conditions. During co-evolution, however, fitness gains were limited, bacterial populations consistently evolved phage resistance, and several phage populations went extinct. Furthermore, the resistance mechanisms varied by osmolality. In lower osmolalities, mutations disrupted phage binding sites, conferring strong resistance. In higher osmolalities, mutations led to increased colonic acid production, producing a mucoid phenotype with weaker resistance. Because mucoidy has been associated with increased bacterial virulence, these findings suggest that gut-relevant osmotic conditions may constrain evolutionary trajectories, favoring resistance strategies that are less effective against phage but potentially more virulent, with important implications for phage therapy design. SignificancePhages offer a promising alternative to antibiotics, but their safety and efficacy strongly depends on the environmental conditions where the bacteria and phages interact. In the human gut, for instance, solute concentrations can vary widely due to factors like food intolerances or laxative use. In this study, we show that such variations significantly impact how bacteria and phages co-evolve. In particular, we find that in higher osmolalities, bacteria evolve phage resistance through mucoidy - a phenotype linked with increased bacterial virulence - rather than receptor loss. This highlights the need to consider environmental factors when developing phage therapies.

Citations
3
FWCI
10.40
Field percentile
top 1%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISGoehlich '22Castledine '25Phan '26Wenner '23Frazao '18Castledine '21
79% semantic matchEvolutionary Biology
H. Goehlich, O. Roth, M. Sieber+5 more·bioRxiv·Oct 28, 2022